Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Early Initiation of Canagliflozin in Patients With Acute Decompansted Heart Failure

NCT05364190 is registered in ClinicalTrials.gov with October 6 University as lead sponsor.

NCT NCT05364190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05364190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Early Initiation of Canagliflozin in Patients With Acute Decompansted Heart Failure
Lead sponsor
October 6 University
Phase
Phase 3
Overall status
Completed
Start date
June 4, 2022
Completion date
March 1, 2024
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, chronic heart failure, diabetes mellitus